Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome.

Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ.

Dig Dis Sci. 2014 Dec;59(12):2913-26. doi: 10.1007/s10620-014-3248-6. Epub 2014 Jun 24.

2.

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580. Review.

3.

Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.

Morrison J, Bronner M, Leach BH, Downs-Kelly E, Goldblum JR, Liu X.

Scand J Gastroenterol. 2011 Nov;46(11):1340-8. doi: 10.3109/00365521.2011.610003. Epub 2011 Aug 31.

PMID:
21879804
4.

Comparative effectiveness of screening strategies for Lynch syndrome.

Barzi A, Sadeghi S, Kattan MW, Meropol NJ.

J Natl Cancer Inst. 2015 Mar 20;107(4). pii: djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.

5.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

6.

Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.

Chen YE, Kao SS, Chung RH.

PLoS One. 2016 Aug 2;11(8):e0160599. doi: 10.1371/journal.pone.0160599. eCollection 2016.

7.

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.

Ferguson SE, Aronson M, Pollett A, Eiriksson LR, Oza AM, Gallinger S, Lerner-Ellis J, Alvandi Z, Bernardini MQ, MacKay HJ, Mojtahedi G, Tone AA, Massey C, Clarke BA.

Cancer. 2014 Dec 15;120(24):3932-9. doi: 10.1002/cncr.28933. Epub 2014 Jul 31.

8.

Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.

Karlitz JJ, Hsieh MC, Liu Y, Blanton C, Schmidt B, Jessup JM, Wu XC, Chen VW.

Am J Gastroenterol. 2015 Jul;110(7):948-55. doi: 10.1038/ajg.2014.417. Epub 2015 Jan 20.

PMID:
25601013
9.

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.

Toon CW, Walsh MD, Chou A, Capper D, Clarkson A, Sioson L, Clarke S, Mead S, Walters RJ, Clendenning M, Rosty C, Young JP, Win AK, Hopper JL, Crook A, von Deimling A, Jenkins MA, Buchanan DD, Gill AJ.

Am J Surg Pathol. 2013 Oct;37(10):1592-602. doi: 10.1097/PAS.0b013e31828f233d.

10.

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

BMC Cancer. 2015 Apr 25;15:313. doi: 10.1186/s12885-015-1254-5.

11.

Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U.

Am J Manag Care. 2012 May 1;18(5):e179-85.

12.

Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.

Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, Moskaluk CA.

Am J Surg Pathol. 2016 Feb;40(2):155-65. doi: 10.1097/PAS.0000000000000544.

PMID:
26523542
13.

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Mvundura M, Grosse SD, Hampel H, Palomaki GE.

Genet Med. 2010 Feb;12(2):93-104. doi: 10.1097/GIM.0b013e3181cd666c.

PMID:
20084010
14.

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H.

Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836. doi: 10.1111/j.1572-0241.2008.02084.x. Epub 2008 Aug 27.

PMID:
18759827
15.

Identification of Lynch syndrome among patients with colorectal cancer.

Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A; EPICOLON Consortium.

JAMA. 2012 Oct 17;308(15):1555-65. doi: 10.1001/jama.2012.13088.

16.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
17.

A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours.

Schofield L, Grieu F, Goldblatt J, Amanuel B, Iacopetta B.

Fam Cancer. 2012 Mar;11(1):1-6. doi: 10.1007/s10689-011-9494-2.

PMID:
22120844
18.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

Schofield L, Goldblatt J, Iacopetta B.

Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22.

19.

Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.

Vindigni SM, Kaz AM.

Dig Dis Sci. 2016 Apr;61(4):969-76. doi: 10.1007/s10620-015-3964-6. Epub 2015 Nov 24. Review.

PMID:
26602911
20.

Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.

Siraj AK, Prabhakaran S, Bavi P, Bu R, Beg S, Hazmi MA, Al-Rasheed M, Al-Assiri M, Sairafi R, Al-Dayel F, Al-Sanea N, Uddin S, Al-Kuraya KS.

Cancer. 2015 Jun 1;121(11):1762-71. doi: 10.1002/cncr.29288. Epub 2015 Feb 24.

Supplemental Content

Support Center